Tradestie Institutional Equity Comparison Engine

SNN vs EW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EW Overall Edge

EW Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNN counters with relative strength in Valuation. Fundamentally, SNN trades at 13.2x Forward P/E with 14.2% operating margin (+4.6% YoY revenue) versus EW at 31.6x Forward P/E and 28.8% operating margin (+10.5% YoY). In options structure, SNN sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SNN
SNN 13.2x vs EW 31.6x Fwd P/E
Growth & Margin Winner EW
Op Margin 14.2% vs 28.8% ยท YoY +4.6% vs +10.5%
Momentum & Technical Winner EW
1Y -5.9% vs +23.9% ยท 52W Pos 45% vs 96%
Options & Structure Winner EW
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (34th %ile IV)
SNN NYSE
Smith & Nephew plc
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$31.01
-0.86% 1D
Market Cap $13.2B
1M Return +6.71%
1Y Return -5.94%
Forward P/E 13.2x
Unified AI Score
42.0 / 100 HOLD
Tech 24.0 Fund 37.0 Flow 50.0 Mom 31.2
EW NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap $60.8B
1M Return +23.16%
1Y Return +23.86%
Forward P/E 31.6x
Unified AI Score
31.5 / 100 SELL
Tech 50.0 Fund 29.0 Flow 51.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNN -5.94% EW +23.86% Spread: +29.8 pp (EW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SNN TTM Op. Margin: 14.2% EW TTM Op. Margin: 28.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNN vs EW. Trailing 12-month operating profitability (SNN 14.2% vs EW 28.8%) and valuation multiples (SNN 13.2x vs EW 31.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNN (4) vs EW (6)
Institutional Metric SNN EW Criterion Row Winner
Market Capitalization Scale $13.2B $60.8B Larger Scale EW
Trailing P/E Ratio Valuation 21.4x 61.5x Lower Multiple SNN
Forward P/E Ratio Valuation 13.2x 31.6x Lower Multiple SNN
Revenue Growth (YoY) Growth +4.6% +10.5% Higher Growth EW
Operating Margin (TTM) Profitability 14.2% 28.8% Higher Margin EW
Net Profit Margin Profitability 10.1% 15.3% Higher Margin EW
Return on Equity (ROE) Capital Efficiency 11.8% 9.3% Higher ROE SNN
52-Week Range Position Momentum 45% ($26โ€“$37) 96% ($75โ€“$108) Stronger Trend EW
Beta / 30D Volatility Risk Regime 0.28ฮฒ ยท 38% Vol 0.44ฮฒ ยท 24% Vol Lower Realized Risk EW
Unified Institutional Score Composite Signal 42.0 / 100 (HOLD) 31.5 / 100 (SELL) Higher Composite SNN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNN vs EW Buy Guide
SNN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SNN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNN nor EW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.